Source link : https://www.newshealth.biz/health-news/trial-data-helped-guide-treatment-of-stage-ii-iii-triple-negative-breast-cancer/
Even when diagnosed early, triple-negative breast cancer (TNBC) has a higher mortality rate compared with other breast cancer subtypes due to its aggressive nature. However, results from the randomized KEYNOTE-522 study showed an improvement in overall survival (OS) in patients with stage II-III TNBC who received pembrolizumab (Keytruda) before and after surgery plus neoadjuvant chemotherapy […]
Author : News Health
Publish date : 2024-12-11 15:36:57
Copyright for syndicated content belongs to the linked Source.